PULMONARY ARTERIAL HYPERTENSION
Clinical trials for PULMONARY ARTERIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
PAH drug study halted early – no patients reached full year
Disease control TerminatedThis study looked at the long-term safety of an experimental drug called LTP001 for people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard for the heart to pump blood. It was an extension study for people who had already completed an earlie…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
PAH drug study halted early: what happened?
Disease control TerminatedThis study tested an experimental drug called LTP001 in 47 people with pulmonary arterial hypertension (PAH), a condition where high blood pressure damages the arteries in the lungs. The goal was to see if the drug could improve blood flow and exercise ability. The study was stop…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 06, 2026 16:04 UTC
-
New hope for rare lung disease: sotatercept trial targets worsening
Disease control TerminatedThis study tested a drug called sotatercept in people newly diagnosed with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. The goal was to see if adding sotatercept to standard treatment could delay worsening of the disease. The tria…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
Xenon MRI sheds light on hidden lung damage in hypertension patients
Knowledge-focused TerminatedThis study aimed to see if a special type of MRI, using xenon gas, could detect changes in the lungs of people with pulmonary hypertension (high blood pressure in the lungs). Researchers looked at how these MRI signals relate to disease severity and progression. The study involve…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Bastiaan Driehuys • Aim: Knowledge-focused
Last updated May 17, 2026 00:32 UTC